These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2543223)

  • 1. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
    Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of conjugated estrogens with and without medrogestone: a prospective study.
    van der Mooren MJ; Leuven JA; Rolland R
    Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women.
    Gerdes LC; Sonnendecker EW; Polakow ES
    Am J Obstet Gynecol; 1982 Jan; 142(1):98-104. PubMed ID: 6275706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations.
    Teichmann AT; Wieland H; Cremer P; Hinney B; Kuhn W; Seidel D
    Maturitas; 1985 Nov; 7(4):343-50. PubMed ID: 3001482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women.
    Farish E; Fletcher CD; Hart DM; Teo HT; Alazzawi F; Howie C
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):123-7. PubMed ID: 3020851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
    Sonnendecker EW; Polakow ES
    S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
    Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
    Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women.
    Krauss RM; Perlman JA; Ray R; Petitti D
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1606-11. PubMed ID: 2837088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women.
    Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J
    Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.
    Julius U; Fritsch H; Fritsch W; Rehak E; Fücker K; Leonhardt W; Hanefeld M
    Clin Investig; 1994 Jul; 72(7):502-7. PubMed ID: 7981577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.
    Fletcher CD; Farish E; Dagen MM; Alazzawi F; McQueen D; Hart DM
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):339-42. PubMed ID: 2837887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
    Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic changes in the endometrium of climacteric women during hormonal treatment.
    Schurz B; Metka M; Heytmanek G; Wimmer-Greinecker G; Reinold E
    Maturitas; 1988 Mar; 9(4):367-74. PubMed ID: 2837621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.
    Watts NB; Notelovitz M; Timmons MC; Addison WA; Wiita B; Downey LJ
    Obstet Gynecol; 1995 Apr; 85(4):529-37. PubMed ID: 7898828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.
    Aguilar-Salinas CA; Arita Melzer O; Sauque Reyna L; Lopez A; Velasco Perez ML; Guillen LE; Gomez Perez FJ; Rull Rodrigo JA
    Isr Med Assoc J; 2001 Feb; 3(2):137-43. PubMed ID: 11344825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.